Tamara Labanowski is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on corporate and securities law for both public and private companies across all stages of growth. She represents life sciences and technology companies throughout their business life cycle, advising clients in a general counsel capacity on a range of matters, including venture capital financings, corporate governance, public offerings, public company disclosure requirements, and SEC compliance matters.
Tamara Labanowski is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on corporate and securities law for both public and private companies across all stages of growth. She represents life sciences and technology companies throughout their business life cycle, advising clients in a general counsel capacity on a range of matters, including venture capital financings, corporate governance, public offerings, public company disclosure requirements, and SEC compliance matters.
- J.D., Harvard Law School
- B.A., Anthropology, University of Maine
Summa Cum Laude with Highest Honors
- State Bar of Massachusetts
- J.D., Harvard Law School
- B.A., Anthropology, University of Maine
Summa Cum Laude with Highest Honors
- State Bar of Massachusetts
Select Public Offerings
- Tenaya Therapeutics in its $207 million initial public offering
- Arcellx in its $124 million initial public offering
- Arcellx in its $112 million follow-on public offering
- Tenaya Therapeutics in its $75 million follow-on offering
- Tenaya Therapeutics in its $50 million follow-on offering
- Tenaya Therapeutics in its $60 million follow-on offering
- Microchip Technology in various debt offerings
Select Private Company Financings
- Novo Holdings in its investment in Route 92 Medical’s $50 million financing
- BioSapien in its $5.5 million pre-Series A financing led by Global Ventures
- Nature’s Toolbox in its $47.5 million Series B financing led by RA Capital
- ThayerMahan in its $30 million Series C financing led by MC2 Security Fund
- Perrone Robotics in its $10 million financing led by CapStone Holdings
Select Other Transactions
- TigaTx in its acquisition by Epsilogen
- Lumos Pharma in its tender offer and merger with Double Point Ventures
- 4me in its strategic investment by PSG
Select Public Offerings
- Tenaya Therapeutics in its $207 million initial public offering
- Arcellx in its $124 million initial public offering
- Arcellx in its $112 million follow-on public offering
- Tenaya Therapeutics in its $75 million follow-on offering
- Tenaya Therapeutics in its $50 million follow-on offering
- Tenaya Therapeutics in its $60 million follow-on offering
- Microchip Technology in various debt offerings
Select Private Company Financings
- Novo Holdings in its investment in Route 92 Medical’s $50 million financing
- BioSapien in its $5.5 million pre-Series A financing led by Global Ventures
- Nature’s Toolbox in its $47.5 million Series B financing led by RA Capital
- ThayerMahan in its $30 million Series C financing led by MC2 Security Fund
- Perrone Robotics in its $10 million financing led by CapStone Holdings
Select Other Transactions
- TigaTx in its acquisition by Epsilogen
- Lumos Pharma in its tender offer and merger with Double Point Ventures
- 4me in its strategic investment by PSG
- Privacy Policy
- Terms of Use
- Accessibility